prnewswire.com
Negativewww.prnewswire.com ·
the addf highlights encouraging progress toward targeting multiple alzheimers pathologies in biogens phase 2 tau study 302773089
TAX_MILITARY_TITLE_OFFICERTAX_FNCACT_OFFICERTAX_DISEASE_ALZHEIMER_DISEASEWB_1331_HEALTH_TECHNOLOGIES
Topic context
This topic has been covered 344688 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
